First Trust NYSE Arca Biotechnology Index Fund (FBT)

NYSEArca • Currently up 0.77 (+0.29%) in today's trading session

6 members of Congress have disclosed 15 trades in First Trust NYSE Arca Biotechnology Index Fund (FBT) via STOCK Act filings. The most recent disclosure was a sale by Garland "Andy" Barr on 11 March 2024. The most active traders have been Michael K. Simpson (8), David B. McKinley (3), and Garland "Andy" Barr (1). Aggregate disclosed activity totals roughly $64K in purchases and $146K in sales (midpoint estimates from bracketed disclosure amounts).

First Trust NYSE Arca Biotechnology Index Fund is currently trading at $266.18, positioned at 82% of its 52-week range ($189.47 – $283.21).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$266.18
24h Change
+0.77 (+0.29%)
52 Week Range
$189.47–$283.21
View on NASDAQ

First Trust NYSE Arca Biotechnology Index Fund Price History and Technical Analysis

Congressional Trading Activity for FBT

Select to highlight on chart
5 transactions
Compliance: 20%
Garland "Andy" Barr11 Mar 202411 Aug 2025SaleStock$1,001 - $15,000N/A
David Kustoff15 Nov 202112 May 2022SaleStock$15,001 - $50,000N/A
Elizabeth Fletcher3 Apr 202013 Aug 2021PurchaseStock$1,001 - $15,000N/A
David B. McKinley18 Sept 201711 May 2018SaleStock$1,001 - $15,000N/A
David B. McKinley14 Sept 201711 May 2018SaleStock$15,001 - $50,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

No overview data available for this stock

No earnings data available for this stock.

Dividends

Dividend History

13 Dec 2024
Amount $1.1726
30 Dec 2021
Amount $2.2140
23 Sept 2015
Amount $0.0200
24 Jun 2015
Amount $0.0650
25 Mar 2015
Amount $0.0480
23 Dec 2014
Amount $0.0524
23 Jun 2008
Amount $0.2697

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

VSMGX

Vanguard LifeStrategy 60/40 Inv Shrs

47
$36.05+0.04 (+0.11%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

FNDF

Schwab Fundamental International Equity ETF

47
$52.76-0.50 (-0.94%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

VTHRX

Vanguard Target Retirement 2030 Fund

47
$44.54+0.04 (+0.09%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

Frequently Asked Questions about FBT

Which members of Congress have traded FBT?
6 members of Congress have disclosed 15 trades in First Trust NYSE Arca Biotechnology Index Fund (FBT) under the STOCK Act. The most active traders are Michael K. Simpson, David B. McKinley, and Garland "Andy" Barr.
When was FBT most recently disclosed by Congress?
The most recent FBT disclosure was a sale by Garland "Andy" Barr on 11 March 2024.
What is the total disclosed congressional trading volume for FBT?
Members of Congress have disclosed approximately $64K in FBT purchases and $146K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in FBT?
This FBT page updates as soon as new STOCK Act disclosures are filed for First Trust NYSE Arca Biotechnology Index Fund. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.